The EPO published international patent application EP3487494A1 claiming 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one or 5-methylene-4-(p-tolyl)pyrrol-2-one for use in treating bacterial respiratory tract infections. The application names inventors Neil James Parry, Paolo Pantalone, and Paul Williams, with designated states covering all EU member states plus associated countries (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

This is a routine patent publication providing public notice of the application's existence and contents. No compliance actions are required from third parties. Competitors developing similar compounds for bacterial respiratory infections should review the patent claims for potential infringement risks or consider filing observations during the examination phase.